Institutional investors hold a majority ownership of CELG through the 80.86% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2016, these large investors purchased a net $12.6 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BMO ASSET MANAGEMENT CORP. Bought 1.9 Million shares of Celgene
CANDRIAM LUXEMBOURG SA Bought 365.6 Thousand shares of Celgene
VANGUARD INVESTMENTS AUSTRALIA L... Bought 208.6 Thousand shares of Celgene